FlyBase Allele Report: Dmel\Lrrk[UAS.cIa]

General Information

Symbol

Dmel\Lrrk^UAS.cIa

Species

D. melanogaster

Name

Saccharomyces cerevisiae UAS construct a of Imai

FlyBase ID

FBal0220786

Feature type

allele

Associated gene

Dmel\Lrrk

Associated Insertion(s)

Carried in Construct

P{UAS-Lrrk.I}

Also Known As

UAS-dLRRK, UAS-dLRRK WT, UAS-dLRRK-WT, UAS-Lrrk^wt, UAS-Lrrk WT

Key Links

Transgenic product class

wild_type

(Imai et al., 2008)

Mutagen

in vitro construct

Nature of the Allele

Transgenic product class

wild_type

(Imai et al., 2008)

Mutagen

in vitro construct

(Imai et al., 2008)

Progenitor genotype

Carried in construct

P{UAS-Lrrk.I}

Cytology

Description

UAS regulatory sequences drive expression of wild-type Lrrk.

(Imai et al., 2008)

Allele components

Component

Use(s)

Regulatory region(s)

UAS

binary expression system - regulatory region

Encoded product / tool

Lrrk

Mutations Mapped to the Genome

Curation Data

Type

Location

Additional Notes

References

Variant Molecular Consequences

Associated Sequence Data

DDBJ / EMBL / GenBank

DNA sequence

Protein sequence

UniProtKB/Swiss-Prot

UniProtKB/TrEMBL

Expression Data

Reporter Expression

Additional Information

Statement

Reference

Marker for

Reflects expression of

Reporter construct used in assay

Human Disease Associations

Disease Ontology (DO) Annotations

Models Based on Experimental Evidence ( 1 )

Disease

Evidence

References

model of Parkinson's disease

CEA

(Penney et al., 2016)

model of Parkinson's disease 8

CEA

(Miozzo et al., 2022, Sarkar et al., 2021)

Modifiers Based on Experimental Evidence ( 1 )

Disease

Interaction

References

model of Parkinson's disease

is ameliorated by eIF4E1^S058911

(Penney et al., 2016)

is ameliorated by Hsap\LRRK2^G2019S.UAS

(Penney et al., 2016)

is ameliorated by S6k^l-1

(Penney et al., 2016)

is ameliorated by mTor^ΔP

(Penney et al., 2016)

model of Parkinson's disease 8

is exacerbated by Fer2^MB09480

(Miozzo et al., 2022)

is ameliorated by Fer2^{fTRG00336.sfGFP-TVPTBF}

(Miozzo et al., 2022)

exacerbates tauopathy

modeled by Hsap\MAPT^R406W.UAS

(Bardai et al., 2018)

exacerbates Parkinson's disease 1

modeled by Hsap\SNCA^QUAS.cOa

(Sarkar et al., 2021)

Comments on Models/Modifiers Based on Experimental Evidence ( 0 )

Disease-implicated variant(s)

Phenotypic Data

Phenotypic Class

abnormal neuroanatomy, with Scer\GAL4^elav-C155

(Lee et al., 2010)

abnormal neuroanatomy, with Scer\GAL4^Mhc.PW

(Lee et al., 2010)

abnormal neuroanatomy | adult stage | progressive, with Scer\GAL4^Fer2.2359

(Miozzo et al., 2022)

abnormal neuroanatomy | adult stage | progressive, with Scer\GAL4^GMR58E02

(Miozzo et al., 2022)

abnormal neuroanatomy | third instar larval stage, with Scer\GAL4^da.G32

(Inoshita et al., 2017)

abnormal neurophysiology | third instar larval stage, with Scer\GAL4^G14

(Penney et al., 2016)

abnormal neurophysiology | third instar larval stage, with Scer\GAL4^how-24B

(Penney et al., 2016)

abnormal neurophysiology | third instar larval stage, with Scer\GAL4^Mhc.PW

(Penney et al., 2016)

decreased cell number | adult stage | progressive, with Scer\GAL4^Fer2.2359

(Miozzo et al., 2022)

decreased cell number | adult stage | progressive, with Scer\GAL4^GMR58E02

(Miozzo et al., 2022)

Phenotype Manifest In

adult dopaminergic PAM neuron | adult stage | decreased number, with Scer\GAL4^Fer2.2359

(Miozzo et al., 2022)

adult dopaminergic PAM neuron | adult stage | decreased number, with Scer\GAL4^GMR58E02

(Miozzo et al., 2022)

embryonic/larval neuromuscular junction | third instar larval stage, with Scer\GAL4^G14

(Penney et al., 2016)

embryonic/larval neuromuscular junction | third instar larval stage, with Scer\GAL4^how-24B

(Penney et al., 2016)

embryonic/larval neuromuscular junction | third instar larval stage, with Scer\GAL4^Mhc.PW

(Penney et al., 2016)

neuromuscular junction, with Scer\GAL4^elav-C155

(Lee et al., 2010)

neuromuscular junction, with Scer\GAL4^Mhc.PW

(Lee et al., 2010)

type I bouton, with Scer\GAL4^elav-C155

(Lee et al., 2010)

type I bouton, with Scer\GAL4^Mhc.PW

(Lee et al., 2010)

type I bouton | third instar larval stage, with Scer\GAL4^da.G32

(Inoshita et al., 2017)

Detailed Description

Statement

Reference

Adults expressing Lrrk^UAS.cIa under the control of Scer\GAL4^Fer2.2359 or Scer\GAL4^GMR58E02 show a progressive decrease in the number of PAM neurons.

(Miozzo et al., 2022)

The expression of Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^da.G32 leads to a significant increase in the number of type Ib synaptic boutons at the third instar larval neuromuscular junction, as compared to controls.

(Inoshita et al., 2017)

Expression of Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^Mhc.PW, Scer\GAL4^G14 or Scer\GAL4^how-24B does not result in any significant difference in amplitude of miniature excitatory junction currents (mEJCs), but does lead to an increase in amplitude of EJCs, and an increase in quantal content of larval neuromuscular junctions, and these phenotypes are present over a range of external calcium concentrations, as compared to controls. Expression of Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^Mhc.PW leads to a significant increase in the size of the readily releasable pool of vesicles, but no significant difference in quantal size or the probability of vesicle release over a range of external calcium concentrations, and does not result in a significant difference in number of synaptic boutons or presynaptic release sites, as compared to controls.

(Penney et al., 2016)

Flies expressing Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^ple.PG do not show a progressive reduction in electroretinogram amplitude (there is no significant difference in the amplitude seen in 3 and 28 day old flies).

(Hindle et al., 2013)

Pre-synaptic or post-synaptic expression of Lrrk^Scer\UAS.cIa (under the control of either Scer\GAL4^elav-C155 or Scer\GAL4^Mhc.PW) results in an estimated 20% decrease in the total number of type I boutons and neuromuscular junction branch number on muscle 6/7 of A3, with no observable effect on muscle size. Neuromuscular length is normal.

(Lee et al., 2010)

The number of dopaminergic neurons in the protocerebral posterior medial 1 and 2 clusters and in the protocerebral posterior lateral 1 cluster and the number of neurons in the protocerebral posterior medial 3 cluster is normal in 60 day old adults expressing Lrrk^{Y1383C.Scer\UAS} under the control of Scer\GAL4^ple.PF.

(Imai et al., 2008)

External Data

Linkouts

Interactions

Show genetic interaction network for Enhancers & Suppressors

Phenotypic Class

Enhanced by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^Fer2.2359 has abnormal neuroanatomy | adult stage | progressive phenotype, enhanceable by Fer2^MB09480/Fer2^MB09480

(Miozzo et al., 2022)

Lrrk^UAS.cIa, Scer\GAL4^Fer2.2359 has decreased cell number | adult stage | progressive phenotype, enhanceable by Fer2^MB09480/Fer2^MB09480

(Miozzo et al., 2022)

Suppressed by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^da.G32 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Vps35^MH20/Vps35[+]

(Inoshita et al., 2017)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by eIF4E1^S058911/eIF4E1[+]

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by S6k[+]/S6k^l-1

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Tor[+]/mTor^ΔP

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Fur1[+]/Fur1^rL205

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Fur1^JF01855, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, suppressible by Hsap\LRRK2^G2019S.UAS, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neuroanatomy phenotype, suppressible by Thor^UAS.cMa, Scer\GAL4^Mhc.PW

(Lee et al., 2010)

NOT suppressed by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^GMR58E02 has decreased cell number | adult stage | progressive phenotype, non-suppressible by Fer2^{fTRG00336.sfGFP-TVPTBF}

(Miozzo et al., 2022)

Lrrk^UAS.cIa, Scer\GAL4^GMR58E02 has abnormal neuroanatomy | adult stage | progressive phenotype, non-suppressible by Fer2^{fTRG00336.sfGFP-TVPTBF}

(Miozzo et al., 2022)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neurophysiology | third instar larval stage phenotype, non-suppressible by Hsap\LRRK2^UAS.cVa, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neuroanatomy phenotype, non-suppressible by Scer\GAL4^elav-C155/Thor^UAS.cMa

(Lee et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has abnormal neuroanatomy phenotype, non-suppressible by Thor^TA.UAS, Scer\GAL4^Mhc.PW

(Lee et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^elav-C155 has abnormal neuroanatomy phenotype, non-suppressible by Thor^TA.UAS/Scer\GAL4^Mhc.PW

(Lee et al., 2010)

Enhancer of

Statement

Reference

Lrrk^UAS.cIa/Scer\GAL4^Fer2.2359 is an enhancer of abnormal neuroanatomy | adult stage | progressive phenotype of Fer2^MB09480

(Miozzo et al., 2022)

Lrrk^UAS.cIa/Scer\GAL4^Fer2.2359 is an enhancer of decreased cell number | adult stage | progressive phenotype of Fer2^MB09480

(Miozzo et al., 2022)

Scer\GAL4^nSyb.PP/Lrrk^UAS.cIa is an enhancer of abnormal locomotor behavior | adult stage phenotype of Hsap\SNCA^QUAS.cOa, Ncra\QF^QF2.nSyb

(Sarkar et al., 2021)

Scer\GAL4^nSyb.PP/Lrrk^UAS.cIa is an enhancer of decreased cell number | adult stage phenotype of Hsap\SNCA^QUAS.cOa, Ncra\QF^QF2.nSyb

(Sarkar et al., 2021)

Lrrk^UAS.cIa, Scer\GAL4^GMR.PF is an enhancer of visible phenotype of Scer\GAL4^GMR.PF, foxo^UAS.cKb

(Kanao et al., 2010)

Suppressor of

Statement

Reference

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of abnormal size | third instar larval stage phenotype of Vps35^MH20/Vps35¹

(Inoshita et al., 2017)

Scer\GAL4^ple.PF/Lrrk^UAS.cIa is a suppressor of abnormal circadian behavior | dominant | adult stage phenotype of Vps35¹

(Inoshita et al., 2017)

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of abnormal neuroanatomy | dominant | third instar larval stage phenotype of Vps35^MH20

(Inoshita et al., 2017)

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of abnormal neurophysiology | dominant | third instar larval stage phenotype of Vps35^MH20

(Inoshita et al., 2017)

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of abnormal locomotor behavior | dominant | third instar larval stage phenotype of Vps35^MH20

(Inoshita et al., 2017)

Lrrk^UAS.cIa, Scer\GAL4^GMR.PFa is a suppressor | partially of visible | adult stage phenotype of Scer\GAL4^GMR.PFa, egr^UAS.cMa

(Ruan et al., 2016)

Other

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^{elav.Switch.PO}, foxo^UAS.cKb has abnormal neuroanatomy | adult stage | RU486 conditional phenotype

(Kanao et al., 2010)

Phenotype Manifest In

Enhanced by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^Fer2.2359 has adult dopaminergic PAM neuron | adult stage | decreased number phenotype, enhanceable by Fer2^MB09480/Fer2^MB09480

(Miozzo et al., 2022)

Suppressed by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^da.G32 has type I bouton | third instar larval stage phenotype, suppressible by Vps35^MH20/Vps35[+]

(Inoshita et al., 2017)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by eIF4E1^S058911/eIF4E1[+]

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by S6k[+]/S6k^l-1

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Tor[+]/mTor^ΔP

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Fur1[+]/Fur1^rL205

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Fur1^JF01855, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Hsap\LRRK2^G2019S.UAS, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has neuromuscular junction phenotype, suppressible by Thor^UAS.cMa, Scer\GAL4^Mhc.PW

(Lee et al., 2010)

NOT suppressed by

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^GMR58E02 has adult dopaminergic PAM neuron | adult stage | decreased number phenotype, non-suppressible by Fer2^{fTRG00336.sfGFP-TVPTBF}

(Miozzo et al., 2022)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has embryonic/larval neuromuscular junction | third instar larval stage phenotype, non-suppressible by Hsap\LRRK2^UAS.cVa, Scer\GAL4^Mhc.PW

(Penney et al., 2016)

Lrrk^UAS.cIa, Scer\GAL4^elav-C155 has neuromuscular junction phenotype, non-suppressible by Scer\GAL4^Mhc.PW/Thor^UAS.cMa

(Lee et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^Mhc.PW has neuromuscular junction phenotype, non-suppressible by Thor^TA.UAS, Scer\GAL4^Mhc.PW

(Lee et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^elav-C155 has neuromuscular junction phenotype, non-suppressible by Thor^TA.UAS/Scer\GAL4^Mhc.PW

(Lee et al., 2010)

Enhancer of

Statement

Reference

Lrrk^UAS.cIa/Scer\GAL4^Fer2.2359 is an enhancer of adult dopaminergic PAM neuron | adult stage | decreased number phenotype of Fer2^MB09480

(Miozzo et al., 2022)

Scer\GAL4^nSyb.PP/Lrrk^UAS.cIa is an enhancer of outer medulla | adult stage phenotype of Hsap\SNCA^QUAS.cOa, Ncra\QF^QF2.nSyb

(Sarkar et al., 2021)

Scer\GAL4^nSyb.PP/Lrrk^UAS.cIa is an enhancer of medulla intrinsic columnar neuron | adult stage | decreased number phenotype of Hsap\SNCA^QUAS.cOa, Ncra\QF^QF2.nSyb

(Sarkar et al., 2021)

Scer\GAL4^nSyb.PP/Lrrk^UAS.cIa is an enhancer of dopaminergic medulla neuron | adult stage | decreased number phenotype of Hsap\SNCA^QUAS.cOa, Ncra\QF^QF2.nSyb

(Sarkar et al., 2021)

Lrrk^UAS.cIa, Scer\GAL4^GMR.PF is an enhancer of eye phenotype of Scer\GAL4^GMR.PF, foxo^UAS.cKb

(Kanao et al., 2010)

Suppressor of

Statement

Reference

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of type I terminal bouton | third instar larval stage phenotype of Vps35^MH20/Vps35¹

(Inoshita et al., 2017)

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of synaptic vesicle | third instar larval stage phenotype of Vps35^MH20/Vps35¹

(Inoshita et al., 2017)

Lrrk^UAS.cIa/Scer\GAL4^da.G32 is a suppressor of type I bouton | third instar larval stage phenotype of Vps35^MH20

(Inoshita et al., 2017)

Lrrk^UAS.cIa, Scer\GAL4^GMR.PFa is a suppressor | partially of eye phenotype of Scer\GAL4^GMR.PFa, egr^UAS.cMa

(Ruan et al., 2016)

Other

Statement

Reference

Lrrk^UAS.cIa, Scer\GAL4^{elav.Switch.PO}, foxo^UAS.cKb has dopaminergic neuron | RU486 conditional phenotype

(Kanao et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^{elav.Switch.PO}, foxo^UAS.cKb has dopaminergic PPL1 neuron | RU486 conditional phenotype

(Kanao et al., 2010)

Lrrk^UAS.cIa, Scer\GAL4^{elav.Switch.PO}, foxo^UAS.cKb has dopaminergic PPM3 neuron | RU486 conditional phenotype

(Kanao et al., 2010)

Additional Comments

Genetic Interactions

Statement

Reference

The expression of Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^da.G32 in a Vps35^MH20 heterozygous background suppresses the increased number of type Ib synaptic boutons observed in the third instar larval neuromuscular junction of either Vps35^MH20 heterozygotes or upon expression of Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^da.G32.

(Inoshita et al., 2017)

eIF4E1^S058911/+, Tor^ΔP/+, Fur1^rL205/+ or S6k^l-1/+ suppresses the increase in excitatory junction current amplitude and quantal content seen in larvae NMJs expressing Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^Mhc.PW.

Co-expression of Fur1^JF01855 suppresses the increase in excitatory junction current amplitude and quantal content seen in larvae NMJs expressing Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^Mhc.PW.

(Penney et al., 2016)

The dot-like small eye phenotype characteristic for flies expressing egr^Scer\UAS.cMa under the control of Scer\GAL4^GMR.PFa is partially suppressed by co-expression of Lrrk^Scer\UAS.cIa.

(Ruan et al., 2016)

The severity of the eye defects caused by expression of foxo^Scer\UAS.cKb under the control of Scer\GAL4^GMR.PF are enhanced by co-expression of Lrrk^Scer\UAS.cIa.

Co-expression of foxo^Scer\UAS.cKb and Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^{elav.Switch.PO} in the presence of RU486 throughout the lifespan has no effect on lifespan. These flies show an age-dependent decrease in the number of PPM1/2, PPM3 and PPL1 neurons.

(Kanao et al., 2010)

The reduction of neuromuscular junctions caused by post-synaptic expression of Lrrk^Scer\UAS.cIa (under the control of Scer\GAL4^Mhc.PW) is fully suppresses by the coexpression of Thor^Scer\UAS.cMa.

Coexpression of Thor^Scer\UAS.cMa in the post-synaptic compartment under the control of Scer\GAL4^Mhc.PW is unable to rescue the neuromuscular junction phenotype caused by presynaptic Lrrk^Scer\UAS.cIa expression (under the control of Scer\GAL4^elav-C155.

The reduction of neuromuscular junctions caused by post-synaptic expression of Lrrk^Scer\UAS.cIa (under the control of Scer\GAL4^Mhc.PW) is unaffected by the coexpression of Thor^TA.Scer\UAS.

Coexpression of Thor^TA.Scer\UAS in the post-synaptic compartment under the control of Scer\GAL4^Mhc.PW is unable to rescue the neuromuscular junction phenotype caused by presynaptic Lrrk^Scer\UAS.cIa expression (under the control of Scer\GAL4^elav-C155.

(Lee et al., 2010)

Xenogenetic Interactions

Statement

Reference

Co-expression of Hsap\LRRK2^{G2019S.Scer\UAS}, but not Hsap\LRRK2^Scer\UAS.cVa, suppresses the increase in excitatory junction current amplitude and quantal content seen in larvae NMJs expressing Lrrk^Scer\UAS.cIa under the control of Scer\GAL4^Mhc.PW.

(Penney et al., 2016)

Complementation and Rescue Data

Rescues

Scer\GAL4^Mhc.PW/Lrrk^UAS.cIa rescues Lrrk^e03680

(Lee et al., 2010)

Scer\GAL4^elav-C155/Lrrk^UAS.cIa rescues Lrrk^e03680

(Lee et al., 2010)

Comments

Muscle expression of Lrrk^Scer\UAS.cIa (under the control of Scer\GAL4^Mhc.PW) rescues the synaptic morphology phenotype and average bouton size found in Lrrk^e03680 homozygous mutants.

Neuronal expression of Lrrk^Scer\UAS.cIa (under the control of Scer\GAL4^elav-C155 results in a partial but still significant rescue of synaptic morphology and average bouton size in Lrrk^e03680 mutants.

Muscle expression of Lrrk^Scer\UAS.cIa (through Scer\GAL4^Mhc.PW) fails to rescue the alterations of mEJC frequency, EJC amplitude, or quantal content in Lrrk^e03680 mutants.

Neuronal expression of Lrrk^Scer\UAS.cIa (through Scer\GAL4^elav-C155) partially rescues EJC amplitude in Lrrk^e03680 mutants, but fails to significantly rescue quantal content.

(Lee et al., 2010)

Images (0)

Mutant

Wild-type

Stocks (0)

Notes on Origin

Discoverer

External Crossreferences and Linkouts ( 0 )

Synonyms and Secondary IDs (3)

Reported As

Symbol Synonym

Lrrk^Scer\UAS.cIa

Lrrk^UAS.cIa

Name Synonyms

Saccharomyces cerevisiae UAS construct a of Imai

Secondary FlyBase IDs

References (14)

Report Sections